John PH Wilding: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in SUSTAIN 1-5 trials

Ahrén, Bo, Atkin, Stephen L, Charpentier, Guillaume, Warren, Mark L, Wilding, John PH, Birch, Sune, Holst, Anders Gaarsdal, Leiter, Lawrence A

Journal:

Diabetes, Obesity and Metabolism

Year:

2018

Language:

english

File:

PDF, 1.54 MB

english, 2018

2

Randomised, cOntrolled Multicentre trial of 26 weeks subcutaneous liraglutide (a glucagon-like peptide-1 receptor Agonist), with or without contiNuous positive airway pressure (CPAP), in patients with type 2 diabetes mellitus (T2DM) and obstructive sleep apnoEa (OSA) (ROMANCE): study protocol assessing the effects of weight loss on the apneaâhypnoea index (AHI)

Sprung, Victoria S, Kemp, Graham J, Wilding, John PH, Adams, Valerie, Murphy, Kieran, Burgess, Malcolm, Emegbo, Stephen, Thomas, Matthew, Needham, Alexander J, Weimken, Andrew, Schwab, Richard J, Manu

Journal:

Year:

2020

File:

PDF, 1.34 MB

2020

3

Emerging sodium/glucose co-transporter 2 inhibitors for type 2 diabetes

Boyle, Luke D, Wilding, John PH

Journal:

Expert Opinion on Emerging Drugs

Year:

2013

Language:

english

File:

PDF, 865 KB

english, 2013

4

Differential vascular dysfunction in response to diets of differing macronutrient composition: a phenomenonological study

Sameer Fatani, Lucy C Pickavance, Claire J Sadler, Joanne A Harrold, Roslyn Cassidy, John PH Wilding, Ebrahim K Naderali

Journal:

Nutrition & Metabolism

Year:

2007

Language:

english

File:

PDF, 239 KB

english, 2007

5

The expanding role of SGLT2 inhibitors beyond glucose-lowering to cardiorenal protection

Brown, Emily, Wilding, John PH, Alam, Uazman, Barber, Thomas M, Karalliedde, Janaka, Cuthbertson, Daniel J

Journal:

Annals of Medicine

Year:

2020

File:

PDF, 1.00 MB

2020

6

Tesaglitazar, as add-on therapy to sulphonylurea, dose-dependently improves glucose and lipid abnormalities in patients with type 2 diabetes

Wilding, John PH, Gause-Nilsson, Ingrid, Persson, Anders

Journal:

Diabetes and Vascular Disease Research

Year:

2007

Language:

english

File:

PDF, 114 KB

english, 2007

7

Combination therapy for obesity

Wilding, John PH

Journal:

Journal of Psychopharmacology

Year:

2017

Language:

english

File:

PDF, 755 KB

english, 2017

8

Dapagliflozin and cardiovascular outcomes in patients with Type 2 diabetes

Al-Bazz, Dalal Y, Wilding, John PH

Journal:

Future Cardiology

Year:

2020

Language:

english

File:

PDF, 1.26 MB

english, 2020

9

A safety evaluation of canagliflozin: a first-in-class treatment for type 2 diabetes

Boyle, Luke D, Wilding, John PH

Journal:

Expert Opinion on Drug Safety

Year:

2014

Language:

english

File:

PDF, 434 KB

english, 2014

10

Urinary proteomic profiling in severe obesity and obstructive sleep apnoea with CPAP treatment

Seetho, Ian W, Ramírez-Torres, Adela, Albalat, Amaya, Mullen, William, Mischak, Harald, Parker, Robert J, Craig, Sonya, Duffy, Nick, Hardy, Kevin J, Burniston, Jatin G, Wilding, John PH

Journal:

Year:

2015

Language:

english

File:

PDF, 2.83 MB

english, 2015

11

Pathophysiology and Aetiology of Obesity

John PH Wilding

Journal:

Medicine (Medicine Publishing Company Ltd)

Year:

2003

Language:

english

File:

PDF, 89 KB

english, 2003

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски